# Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma

> **NCT03934801** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 140 (actual)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** Brainstorming 1
- **OTHER:** Ranking Round 1
- **OTHER:** Ranking Round 2
- **OTHER:** Ranking Round 3

## Key facts

- **NCT ID:** NCT03934801
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-09-26
- **Final completion:** 2019-09-26
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03934801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03934801, "Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03934801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*